1 year return (CAGR)
-57.60%
Kinnate Biopharma Inc Exchange (NASDAQ, USD)
KNTE
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-56.02%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
124.99M
Price/Sales
-
Ent value
82.27M
Price/Book
0.78
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 2.65 |
| Daily high | 2.65 |
| Daily low | 2.65 |
| Daily Volume | 2.12M |
| 1y analyst estimate | 2.36 |
| Beta | 1.34 |
| EPS (TTM) | -2.35 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| KNTE | S&P500 | |
| Current price drop from All-time high | -94.14% | -0.72% |
| Highest price drop | -97.64% | -56.47% |
| Date of highest drop | 27 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -71.22% | -10.68% |
| Avg time to new high | 279 days | 12 days |
| Max time to new high | 833 days | 1805 days |
News
No items found